This approach ensured that all potential inhibitors of the PRL signaling cascade were identified, and that ‘hits’ recognized by the more sensitive, non-human lymphocytes also blocked PRL signaling in PRLR-expressing breast cancer cells. This evidence concerns the gene PRL and breast carcinoma.